Effects of Hydrotherapy in Children With Cerebral Palsy
Evaluation of the Effects of Hydrotherapy on Balance and Selective Motor Control in Children With Cerebral Palsy
Gaziosmanpasa Research and Education Hospital
36 participants
Jan 22, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this observational study is to learn the effects of hydrotherapy in children with cerebral palsy. It aims to answer if hydrotherapy is affective on balance and selective motor control of the children with cerebral palsy.
Eligibility
Inclusion Criteria5
- Diagnosed with Cerebral Palsy by a specialist physician
- Aged between 4-18 years
- Cooperative with physiotherapy applications
- Gross Motor Function Classification System (GMFCS) levels 1-4
- Willing to participate in the study and undergo assessments
Exclusion Criteria10
- Mental retardation or insufficient cognitive function to comply with study assessments
- GMFCS level 5
- Presence of an intrathecal baclofen pump for spasticity treatment or history of soft tissue and/or bone surgery
- Active infection or localized skin infection at the injection site
- History of active seizures
- Presence of contractures
- Serious systemic disease that may prevent exercise participation
- Injury and/or surgery within the last 6 months
- Botulinum toxin injection within the last 6 months
- Contraindications to hydrotherapy, including severe fear of water, behavioral problems, shortness of breath at rest, infection, incontinence, known chlorine allergy, open wounds, acute systemic illness, epilepsy, tracheostomy, permanent drains, immunodeficiency.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients in the study group will undergo individualized water-based exercises (including standing, balance, weight shifting, breathing exercises, range of motion, stretching, and strengthening exercises) under the supervision of an experienced physiotherapist, 2-3 times per week for six weeks. Additionally, routine conventional exercises will be continued daily for six weeks.
Patients in the control group will continue passive, active, active-assisted, or resistance-based upper and lower extremity conventional exercises appropriate to their functional level and muscle strength. They will be instructed to perform these exercises 2-3 times per week, with each session lasting no more than 45 minutes, for six weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06899035